Paul Chang, PhD

Dr. Paul Chang assists clients in safeguarding their innovations during IP procurement and beyond, particularly in the life sciences industry. With advanced training in both life sciences and computer science, Paul is well-suited to handle complex and inter-disciplinary technologies. Clients entrust him with securing patent protections in areas like genomics, bioinformatics, personalized medicine, and AI, covering everything from instrument platforms to data collection and analyses to disease diagnosis and treatment. Paul’s excellence has been recognized by Best Lawyers: Ones to Watch 2021-2026.

Paul has considerable experience working with platform biotechnologies such as flow cytometry, mass spectrometry, and microfluidics. His work also extends to data mining and analytics, artificial intelligence and machine learning, in the life sciences space as well as the high technology spaces.

Beyond securing IP rights, Paul assists clients with validity and invalidity analyses, infringement studies, IP due diligence investigations, clearance investigations, and IP licensing and negotiations. He is committed to ensuring that IP strategies align with his clients’ business goals, whether they are individual inventors, academic institutions, startups, or multinational corporations.

• Retained by a large pharmaceutical company to handle intellectual property matters.
• Retained by a client to license worldwide IP rights to a novel therapeutic agent targeting cancer.
• Retained to handle the intellectual property matters of a nonprofit research institute dedicated to basic and translational research.